Literature DB >> 19956180

MicroRNAs as potential cancer therapeutics.

P Trang1, J B Weidhaas, F J Slack.   

Abstract

MicroRNAs (miRNAs) have been shown to have an important role in various cellular processes, such as apoptosis, differentiation and development. Recent studies have shown that miRNAs are mis-expressed in human cancers where they can exert their effect as oncogenes or tumor suppressors. Here, we review the potential for using miRNAs as biomarkers for diagnosis, prognosis and cancer therapies.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19956180     DOI： 10.1038/onc.2009.353

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


  110 in total

1.  Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients.

Authors:  Moubin Lin; Jian Gu; Cathy Eng; Lee M Ellis; Michelle A Hildebrandt; Jie Lin; Maosheng Huang; George A Calin; Dingzhi Wang; Raymond N Dubois; Ernest T Hawk; Xifeng Wu
Journal:  Clin Cancer Res       Date:  2012-06-01       Impact factor: 12.531

2.  MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.

Authors:  Ji-Qun Geng; Xiao-Chen Wang; Long-Fei Li; Jun Zhao; Song Wu; Gui-Ping Yu; Kou-Jun Zhu
Journal:  Tumour Biol       Date:  2015-09-10

3.  Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport.

Authors:  Magnus Ingelman-Sundberg; Xiao-Bo Zhong; Oliver Hankinson; Sudheer Beedanagari; Ai-Ming Yu; Lai Peng; Yoichi Osawa
Journal:  Drug Metab Dispos       Date:  2013-08-05       Impact factor: 3.922

4.  Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity.

Authors:  Mei-Mei Li; Balasubrahmanyam Addepalli; Mei-Juan Tu; Qiu-Xia Chen; Wei-Peng Wang; Patrick A Limbach; Janine M LaSalle; Su Zeng; Min Huang; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2015-05-01       Impact factor: 3.922

Review 5.  Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.

Authors:  P Mapelli; E O Aboagye; J Stebbing; R Sharma
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

6.  Extracellular vesicles from osteosarcoma cell lines contain miRNAs associated with cell adhesion and apoptosis.

Authors:  Sofía Jerez; Héctor Araya; Daniel Hevia; Carlos E Irarrázaval; Roman Thaler; Andre J van Wijnen; Mario Galindo
Journal:  Gene       Date:  2019-06-06       Impact factor: 3.688

7.  Comparative profiling of miRNA expression of lung adenocarcinoma cells in two-dimensional and three-dimensional cultures.

Authors:  Cui Li; Hong T Nguyen; Yan Zhuang; Zhen Lin; Erik K Flemington; Ying Zhuo; Stephen P Kantrow; Gilbert F Morris; Deborah E Sullivan; Bin Shan
Journal:  Gene       Date:  2012-10-02       Impact factor: 3.688

Review 8.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

9.  miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells.

Authors:  Wenming Qin; Yi Shi; Botao Zhao; Chengguo Yao; Li Jin; Jiexian Ma; Youxin Jin
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

10.  Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells.

Authors:  Claire Gourzones; Aurore Gelin; Izabela Bombik; Jihène Klibi; Benjamin Vérillaud; Joël Guigay; Philippe Lang; Stéphane Témam; Véronique Schneider; Corinne Amiel; Sonia Baconnais; Anne-Sophie Jimenez; Pierre Busson
Journal:  Virol J       Date:  2010-10-15       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.